Myeloid differentiation 1 (MD-1) is a secreted protein that regulates the immune response of B cell through interacting with radioprotective 105 (RP105). 
| INTRODUC TI ON
Obesity is a metabolic disorder affecting millions of people worldwide. Patients with obesity are highly vulnerable to cardiovascular dysfunctions, including hypertrophic cardiomyopathy. 1, 2 Featured with impaired diastolic function and left ventricular hypertrophy, obesity cardiomyopathy (OCM) patients exhibited disrupted substrate metabolism, oxidative stress, endoplasmic reticulum stress in the early stage. [2] [3] [4] [5] [6] [7] These events cause the accumulation of lipid droplets in cardiomyocytes, changing the immune response and resulting in cardiac fibrosis, remodelling and compromised cardiac functions. [8] [9] [10] In the process, immune system is vital in modulating the development of diabetic cardiomyopathy. 9 However, the underlying mechanism is not fully understood.
Myeloid differentiation 1 (MD-1) is a secreted glycoprotein produced by macrophages. 11 It forms complex with radioprotective 105 (RP105), a Toll-like receptor protein, to play critical roles in lipopolysaccharide (LPS) recognition by B cells. [11] [12] [13] Recent studies have revealed that MD-1/RP105 complex as a key regulator of high-fat diet induced chronic inflammation in obesity. 14, 15 Moreover, RP105 was proved to play cardioprotective function in against myocardial ischaemia-reperfusion injury by suppressing TLP4 signalling pathways. 16, 17 As an indispensable accessory molecule required for the cell surface expression of RP105, 18 whether MD-1 may also play essential roles in cardiac diseases needs to be further explored. Recently, Jiang et al reported that loss of MD1 exacerbated myocardial I/R injury and increased the susceptibility to ventricular arrhythmia, both of which are possibly related to the up-regulation of TLR4/NF-κB signalling pathway. 19 Another study found that MD1 deficiency played an important role in accelerating the development of inflammatory atrial fibrosis and increasing vulnerability to AF in mice with HFD-fed induced obesity. 20 In our previous research, we have verified MD-1 is a vital modulator of cardiac hypertrophy and fibrosis. 21 Thus, we hypothesized that MD-1 may also play vital effects in obesity-induced cardiomyopathy.
In this study, utilizing free fatty acid (FFA) containing palmitic acid and oleic acid to mimic high-fat environment in H9C2 cells, or 
| MATERIAL S AND ME THODS

| Reagents
Palmitic acid and oleic acid were purchased from Sigma Aldrich (USA). Inhibitors U0126 and Bay 11-7082 were purchased from Selleck Chemicals (USA).
| Cell culture and high-fat stimulation
Rat cardiomyocytes H9C2 cells were purchased from ATCC and cultured in Dulbecco's modified essential medium (DMEM) supplemented with 10% foetal bovine serum (FBS), 2 mmol/L glutamine, 1 mmol/L pyruvate, 100 U/mL penicillin and 100 mg/mL streptomycin.
Cells were maintained in a humidified incubator with 5% CO 2 at 37°C.
Free fatty acid (FFA), containing oleic acid and palmitic acid at 2:1 molar ratio, was prepared with fat-free bovine serum albumin (BSA)
as previously described 22, 23 and then added into the complete medium with final concentration of 0.25, 0.5 and 1 mmol/L. The control group was treated with 1% BSA. After treated with FFA for 16, 24 or 48 hours, cells were collected for analysis. 
| MTT assay
| Oil red staining
The lipid deposition within the cells was assessed by oil red O staining. H9C2 cells were fixed with pre-cooled 4% formaldehyde. Then cells were stained with oil red O (Sigma-Aldrich) and counterstained with hematoxylin to visualize lipid vacuoles. Images were photographed with microscope (Olympus, Tokyo, Japan).
| Construction and infection of the recombinant adenovirus
The full coding region of the human MD-1 gene controlled by the cytomegalovirus (CMV) promoter was cloned into a replication-defective adenoviral vector (Ad-MD-1). Parallelly, adenoviral vector containing GFP gene (Ad-GFP) was used as control. Short hairpin RNAs (shRNAs) for MD-1 knockdown and the negative control shRNA (shRNA-NC) constructs purchased from GenePharma (Shanghai, China) were used to generate MD-1 knockdown adenovirus (Ad-shMD-1) and control (Ad-shNC) respectively. After packaging, amplification and purification, the viral titres were measured by a plaque assay with fluorescence counting in HEK-293 cells.
Cardiomyocyte H9C2 cells were infected with these adenoviruses at a multiplicity of infection (MOI) of 100.
| RNA extraction and quantification polymerase chain reaction
Total RNA was extracted from H9C2 and mouse tissues using Trizol Reagent (Invitrogen, Paisley, UK) and cDNA was synthesized by reverse transcription using PrimeScript 1st Strand cDNA Synthesis Kit (Takara). The gene expression was measured by quantification polymerase chain reaction (qPCR) with Applied Biosystems 7500
Fast Real Time qPCR machine. The relative expression levels were calculated using 2 −∆∆Ct method, and GAPDH was used as an internal reference. The sequences of primers used for qPCR were listed in 
| Western blot
Total protein was extracted and separated on 8%-10% SDS-PAGE. (#4511), p38 (#9212) and GAPDH (#5174) used for internal reference were purchased from Cell Signaling Technology (Danvers, MA). The membranes were washed and then incubated with HRP-conjugated secondary antibody (1:5000) for 1 hour. Finally, the membranes were washed and exposed to ECL (Millipore) substrate and visualized using the chemiluminescence detection system (Bio-Rad). The intensity of the bands was quantified using Image J software tools.
| MD-1 overexpression or knockdown transgenic mice
The 
| Glucose tolerance testing
Two days before end of the 20th week of HD feed, a glucose tolerance test (GTT) was performed on all these mice. Briefly, all mice were subjected to an overnight fast (≈16 hours) before test. Glucose at dose of 2 g/kg·body-weight was intraperitoneally injected into the mice. At 0 minute before glucose injection and at 15, 30, 60, 90 and 120 minutes after glucose injection, the blood glucose was measured, respectively, using a glucometer (OneTouch Ultra, Johnson & Johnson, USA) through collecting blood from tail vein.
| Echocardiography and serum lipid index analysis
At the end of treatment, mice were anesthetized by intraperitoneally injecting with 3% pentobarbital sodium at a dose of 30 mg/ kg. Half hour later, the mice were fixed on the test plate, removed the hairs and coated with conductive fluid on the heart, then echocardiography analysis was performed using an ultrasonic apparatus After echocardiography experiments, mice were sacrificed.
Serum was collected for biochemical determination including total
mmol/L) and creatine kinase-MB (CK-MB, U/L). The hearts
were dissected and weighed to compare heart weight (HW, g), body
weight (BW, g), the ratios of HW/BW (%) and heart weight to tibia length (HW/TL, mg/mm).
| Masson's trichrome staining and immunohistochemistry
Paraffin-embedded sections from heart tissues were stained with
Masson's trichrome to determine the degree of cardiac fibrosis. Masson's trichrome staining kit was purchased from Sigma Aldrich (MO, USA) and sections were stained according to the manufacturer's instruction.
For immunohistochemistry, the slices were deparaffinized, hydrated and treated for antigen retrieval, and then incubated with NF-κB p65 primary antibody (1:500 dilution, Abcam, USA) at 4°C for overnight. The positive reactions were visualized as brown using a DAB (3, 3-diamino-benzidine) kit (Sigma, USA) and haematoxylin for nuclear counterstaining. 
| Statistics analysis
| RE SULTS
| FFA induces lipid accumulation and MD-1 differential expression in cardiomyocytes
To create a high-fat induction in vitro, FFA, containing oleic acid and palmitic acid at 2:1 molar ratio, was used to stimulate H9C2 
| Overexpression of MD-1 alleviated high-fat diet induced cardiac dysfunction in vivo
To further confirm the effects of MD-1 on heart function in vivo by high-fat diet feed, transgenic mice overexpressing specially in myocardial cells by the α-myosin heavy chain (α-MHC) promoter were generated. Western blot validated that the overexpression efficiency in transgenic mice (TG) compared to wild-type mice (WT), and the MD-1 protein level was almost tripled ( Figure 5A ). The enhanced activity of serum CK-MB by HD feed was observably suppressed in TG mice than WT mice ( Figure 5B ), indicating that cardiac damage induced by HD were alleviated by overexpression of MD-1. The serum lipid indexes for TC, triglyceride and LDL and body weight were elevated remarkedly in mice by HD feed (Table 3 and Figure 5C ); however, there was no significant difference between the HD-treated TG mice and WT mice on these indexed except TC (Table 3 and Figure 5C ). The HW, ratios of HW/BW and HW/TL of TG hearts were lower markedly than WT hearts after HD feed ( Figure 5D -F).
Slight reduced glucose tolerance was observed in mice with HD treatment, however, there was no difference between TG mice and For cardiac function analysis, echocardiographic measurements were also performed in TG and WT mice. The heart rate was faster in TG mice after HD feed than ND feed; however, the increase in heart rate in TG mice compared to WT was no significant ( Figure 6A ). The IVSd and IVSs were decreased in TG hearts than WT hearts after HD feed ( Figure 6B,C) ; however there was no significant difference in LVDd, LVDs or FS in TG hearts ( Figure 6D ). The increased perivascular and interstitial fibrosis induced by HD feed was reduced remarkedly in TG hearts compared to WT hearts ( Figure 6E) . Consistently, the mRNA levels of COL1A1, COL3A1 and CTGF were down-regulated significantly in TG hearts than WT hearts with HD feed ( Figure 6F ). All these results indicated that overexpression of MD-1 alleviated the myocardial dysfunction induced by HD feed through inhibiting cardiac fibrosis.
| MD-1 mediated HD-induced cardiac pathological remodelling via negatively regulating MAPK and NF-κB signalling
Compared with normal diet, high-fat diet administration markedly decreased the expression of MD-1 in WT mice hearts and transgenic mice hearts; however, the effect of HD was less in TG group than in WT group (Figure 7A,B) . Since MD-1 is reported to deliver cardiac protection against cardiac hypertrophy and suppresses cardiac dysfunction during the remodelling process through modulating MEK-ERK 1/2 and NF-κB signalling pathways. 19 Thus, we investigated the expression of MAPK and NF-κB pathways in the hearts of mice 
| D ISCUSS I ON
Obesity is known to contribute to the development of cardiomyopathy. 3, [24] [25] [26] [27] Although the underlying mechanism has been studies suggesting that MD-1 was benefit to protect myocardial function against high-fat damage.
Here we reported that both NF-κB and MAPK were activated by high-fat stimulation in vivo and in vitro, and inhibiting them with corresponding inhibitors ameliorated cardiac hypertrophy and fibrosis in MD-1 deletion mice. NF-κB is a critical transcription factor that participates in the TLR4/MD-2 signalling and fibrosis in diet-induced obesity, 31 and its role in cardiac remodelling has been intensively studied. [32] [33] [34] Recent evidences suggested that RP105 attenuates ischaemia/reperfusion-induced myocardial injury via suppressing the activation of the TLR4/NF-κB signalling pathway. 35, 36 Our research term also have proved that MD1 negatively regulated MEK-ERK1/2 and NF-κB signalling pathways and rescued the adverse effects on pressure-overload induced cardiac remodelling. 
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